<DOC>
	<DOCNO>NCT01307046</DOCNO>
	<brief_summary>This study conduct evaluate efficacy MK-0954A essential hypertension participant adequately control losartan .</brief_summary>
	<brief_title>MK-0954A Japanese Patients With Essential Hypertension Not Adequately Controlled With Losartan ( MK-0954A-352 )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>Inclusion criterion : Participant diagnosis essential hypertension . Participant treat antihypertensive medication meet protocolspecified blood pressure criterion . Participant treat single antihypertensive medication , meet protocolspecified blood pressure criterion . Participant treat dual oral antihypertensive medication , able discontinue prior antihypertensive medication . Participant clinically meaningful finding disqualify study discretion investigator . Exclusion criterion : Regarding hypertension , participant currently take &gt; 2 antihypertensive medication . Participant history significant multiple and/or severe allergy ingredient Nulotan Preminent thiazide drug relate drug ( i.e. , sulfonamidecontaining `` chlortalidone '' medicine ) Participant , time signing informed consent , user recreational illicit drug recent history within last year drug alcohol abuse dependence . Participant pregnant breastfeeding expect conceive positive pregnancy test screen visit . Participant currently participate participate study investigational compound ( except losartan dos ) device within 30 day sign informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Essential hypertension</keyword>
	<keyword>Uncontrolled hypertension</keyword>
	<keyword>Antihypertensive agent</keyword>
	<keyword>Blood pressure</keyword>
</DOC>